Header image alt text

Niu Huang's Lab


Niu Huang Ph.D.

Niu Huang Ph.D. (黄牛博士)
Niu Huang, Ph. D.
Associate Investigator
National Institute of Biological Sciences (NIBS), Beijing
No. 7 Science Park Road, Zhongguancun Life Science Park
Changping District, Beijing 102206, P. R. China
Fax:    86-010-80720813


The opening of the 21st century has marked with the sequencing of the human genome. Today, the understanding of the sequence, structure and function of biologically relevant targets is growing rapidly and researchers from multi-disciplines, physics and computational science in particular, are making significant contributions to modern biology and drug discovery.

We are interested in developing and applying computational chemistry approaches to study the structural and energetic basis of molecular recognition (i.e. protein-ligand, protein-DNA and protein-protein interactions). Aside from its fundamental biological interest, such theoretical studies have tremendous practical values of which one of the most important is structure-based drug design.

Our lab has successfully applied computational approaches to discover first-in-class drug lead compounds against novel drug targets in the fields of obesity, cancer and fibrosis. Currently, we are actively pursuing experimental collaborations in developing these novel drug candidates.



Sep, 90 – July, 94

University of Nankai, Tianjin, Bachelor of Biophysics
Department of Physics

Sep, 98 – Oct, 2003

University of Maryland at Baltimore, Ph.D. candidate
Department of Pharmaceutical Sciences
Specialization: Computational Chemistry
Advisor: Prof. Alexander D. MacKerell, Jr.




Sep, 94 – Aug, 98

Institute of Materia Medica, Research Assistant
Department of Medicinal Synthetic ChemistryPeking Union of Medical College & Chinese Academy of Medical Sciences
Specialization: Computer-aided Drug Design
Advisor: Prof. Zongru Guo

Oct, 03 – Sep, 07

University of California at San Francisco, Postdoctoral associate
Depts. of Pharmaceutical Chemistry and Biopharmaceutical Sciences
Specialization: Molecular docking methods and scoring functions
Advisors: Profs. Brian Shoichet and Matt Jacobson

Oct, 07 -Aug 2013

National Institute of Biological Sciences, Beijing
Assistant Investigator

Aug,2013 – Present

National Institute of Biological Sciences, Beijing
Associate Investigator



  • WuXi PharmaTech Life Science and Chemistry Award, 2013.
  • Science and Technology Progress 2nd Award from Department of Health, China. “Drug design, synthesis and evaluation based on retinoid nuclear receptors” by Zongru Guo, Rui Han, Fengmin Chu, Minmin Wang, Niu Huang, et al. 1999. Award Number-99201304.
  • Dr. Frank Slama Endowed Fellowship & Merit Award, 2001-2002, Department of Pharmaceutical Sciences, University of Maryland, Baltimore.
  • H.A.B Dunning Fellowship & Merit Award, 2002-2003, Department of Pharmaceutical Sciences, University of Maryland, Baltimore.
  • Reviewers for Proteins, PLoS. Comp. Biol., J. Med. Chem., J. Phys. Chem., JACS, BMC Bioinformatics, Chem. Med. Chem., Chem. Bio. & Drug Design, Bioorg. Med. Chem., J. Comp. Aided Mol. Des., Acta Pharmaceutica Sinica. and Science China Chemistry.


  • BIAMIDO HETEROCYCLIC DERIVATIVE WITH ANTITUMOR ACTIVITY AND ITS PREPARATION METHOD AND USE by Chunzheng Yang, Hui Peng, Jin Qi, Niu Huang, Jianxiang Wang, Ping Xie, Caiyun Wang and Yuan Zhou. (Pub. No.: CN1597668)
  • IMMUNOMODULATORY COMPOUNDS THAT TARGET AND INHIBIT THE pY+3 BINDING SITE OF TYROSENE KINASE p56 LCK SH2 DOMAIN by Alex MacKerell, Jun Hayashi, Ashish Nagarsekar, Niu Huang and Alba Macias. (Pub. No.: PCT/US03/39501) Licensed to A&G Pharmaceutical. INC..
  • SUBSTITUTED HYDROXY ACETOPHENONE AGENTS USED FOR METABOLIC DISEASES by Jijie Chai, Niu Huang, Zhifu Han, Shiming Peng and Tianhui Niu. (Pub. No.: CN 102652749 A)
  • ANTIOBESITY COMPOUNDS THAT TARGET AND INHIBIT FTO PROTEIN by Niu Huang, Gang Zhi, Jijie Chai, Shiming Peng and Nannan Hou. (App. No.: 201210497436.7)


  • Solvent Property Analysis program (SPA 1.0) by Hanzi Sun, Lifeng Zhao and Niu Huang. (Reg. No.: 2013SR008306)
  • Cross-link Molecular Dynamics program (XLMD 1.0) by Lifeng Zhao, Yao Wu and Niu Huang. (Reg. No.: 2013SR008308)


  1. Niu Huang, Nilesh K. Banavali and Alexander D. MacKerell, Jr. Probing the Mechanism of Base Flipping in DNA via Potential of Mean Force Calculations. 34th Middle Atlantic Regional Meeting, American Chemical Society, 2001
  2. Niu Huang, Jun Hayashi and Alexander D. MacKerell, Jr. Application of Computer Screening Tools to Investigate Protein-Protein Interaction: Database Mining Studies on the Tyrosine Kinase p56-Lck SH2 Domain. 220th ACS National Meeting, Aug 2000, Washington D, C
  3. Niu Huang, Nilesh K. Banavali and Alexander D. MacKerell, Jr. Probing the Mechanism of Protein-facilitated Base Flipping via Potential of Mean Force Calculations. 224th ACS National Meeting, Aug 2002, Boston; Gordon Research Conference in Computational Chemistry, New London, 2002
  4. Niu Huang (invited talks), Computational Chemistry in Structural Biology and Pharmaceutical Sciences. National Cancer Institute, July, 08th, 2003,Frederick , MD University of California San Francisco, Sept, 15th, 2003, San Francisco, CA
  5. Niu Huang (invited talk and poster section), Automating and Improving Virtual Screening of Large Compound Databases. 226th ACS National Meeting, Aug 2004, Philly, PA
  6. Niu Huang (invited talk), In-Silico Biology. South Illinois University, Medical School, Sept, 24th, 2004, Springfield, IL
  7. Niu Huang (invited talk), The cycle of life – probing the DNA base flipping mechanism via molecular dynamics based free energy calculations. Mini-Symposium on Molecular Dynamics, Oct, 26th, 2004, UCSF
  8. Niu Huang, CK Kalyanaraman and Matthew P. Jacobson. Developing and Applying a Physics-based Scoring Method to Improve Large Scale Virtual Screening against HIV/AIDS Related Molecular Targets. The Nineteenth Meeting of Groups Studying the Structures of AIDS-related Systems and their Application to Targeted Drug Design, June, 23-24th, 2005, NIH, Bethesda, MD
  9. Niu Huang (invited talk), Computational Chemistry in Structure Biology and Drug Design. The Fourth Sino-US Symposium on Medicine in the 21 Century. Aug, 19-21st, 2005, San Francisco, CA
  10. Niu Huang (invited talk), Automating, Benchmarking and Improving Small Molecule Docking. University of Maryland, Baltimore, School of Pharmacy, July, 2007, Baltimore, MD
  11. Niu Huang (poster sections), Physics-based Scoring of Protein-ligand Complexes. Investigating Bias in Docking Screens with Target, Ligand and Decoy Benchmarking Sets. 232th ACS National Meeting, Sep 2006, San Francisco, CA
  12. Niu Huang (invited talk), Virtual Screening Studies Targeting the Tyrosine Kinase p56 Lck SH2 Domain. Zhengzhou University, Jan 2008, Henan Province, China
  13. Niu Huang (poster section), Tying Protein Druggability Prediction with Fragment-based Virtual Screening. Computational Protein Structure and Mechanics (PSAM) 2008, Sept 12th, Shanghai, China
  14. Niu Huang (invited talks), Physics-based Scoring Method in Drug Discovery. Institute of Materia Medica, CAMS&PUMC, Feb 2009, Beijing, China; Shanghai JiaoTong University, Dept. Chemistry, Dec 2008, Shanghai, China; Beijing University, Center for Theoretical Biology, Nov 2008, Beijing, China; Shandong University, Nov 2008, Jinan, China
  15. Niu Huang (invited talk), Free-energy Guided Ligand Discovery. Symposium on Drug Molecule Design, CNCBD, May 2009, Shengzhen, China
  16. Niu Huang (talk and poster section), Identifying novel CPAF inhibitors via physics-based binding energy calculation methods. Anticancer Mechanism of a Novel Bis-chelated Gold Diphosphine Compound. 239th ACS National Meeting, Mar 2010, San Francisco, CA
  17. Niu Huang (invited talk), Anticancer Mechanism of a Novel Bis-chelated Gold Diphosphine Compound. 10th Beijing Life Science Annual Conference, April 2010, Beijing
  18. Niu Huang (invited talk), Physics-based Scoring Method in Early Stages of Drug Discovery BIT’s 1st Annual International Conference of Medichem, May 2010, Beijing. PKU-Pfizer Symposium on Drug Discovery and Chemical Biology, May 2010, PKU, Beijing
  19. Niu Huang (invited talk), Treating Explicit Water in Docking and Scoring. 240th ACS National Meeting, Aug 2010, Boston, MA
  20. Niu Huang (talk), HATs off: Identification of Novel Inhibitors of the Histone Acetyltransferases via Structure-based Virtual Screening Methods. 241th ACS National Meeting, Mar 2011, Anaheim, CA
  21. Niu Huang (talk), Molecular Modeling of Janus Kinase 2 (JAK2) Pseudokinase-Kinase Complex Structure. 11th Computational Chemistry Conference, July 2011, Lanzhou, Gansu Province, China
  22. Niu Huang (talk), Life Beyond Kinases: Structure-based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors. Protein Structure-based Drug Design, CSHA, Sep 2011, Su Zhou, Jiangsu Province, China
  23. Niu Huang (invited talks), Marrying Physics to Biology. Peking University Shengzhen Graduate School, Nov 2011, Shengzhen, China 1st Multidisplinary Biology Conference, Nov 2011, Beijing, China
  24. Niu Huang (invited talks), Physics-based Scoring Method in Early Stages of Drug Discovery. Merck Research Laboratory, March 2012, NJ, USA; D. E. Shaw Res., Dec 2011, NYC, USA;
  25. Niu Huang (talk), Life Beyond Kinases: Structure-based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors. 243th ACS National Meeting, March 2012, San Diego, CA, USA
  26. Niu Huang (invited talk), Marrying Physics to Biology. Beijing Computational Science Research Center, Aug 2012, Beijing, China


  1. Niu Huang, Minmin Wang, Fengmin Chu and Zongru Guo. Studies on the Structure-Activity Relationship of Retinoids: I. 3D-QSAR of Retinoidal Anti-Carcinogenic Activities. Acta Pharmaceutica Sinica. 1996, 31(12): 932-939
  2. Minmin Wang, Niu Huang, Guangzhong Yang and Zongru Guo. Studies on the Structure-Activity Relationship of Retinoids: II. 3D-QSAR of Retinoids and Receptor Interaction. Acta Pharmaceutical Sinica. 1997, 32(1): 43-48
  3. Qiqin Zhu, Zongru Guo, Niu Huang, Minmin Wang, and Fengming Chu. Comparative Molecular Field Analysis of a Series of Taxol Analogues. J. Med. Chem, 1997, 40: 4319-4328
  4. Niu Huang, Fengmin Chu and Zongru Guo. Studies on the Structure-Activity Relationship of Retinoids: Hansch Analysis and 3D-QSAR Studies on Specific Ligands of Retinoid X Receptor. Acta Pharmaceutica Sinica. 1998, 33: 442-448
  5. Niu Huang, Linbo Qu, Qiqing Zhu, Fengming Chu, Guangzhong Yang and Zongru Guo. Studies on the Structure-Activity Relationship of Retinoids: Molecular Modeling of Interaction between Selective Retinoids Nuclear Receptors. Acta Pharmaceutica Sinica.1999, 34: 358-362
  6. Niu Huang and Alexander D. MacKerell, Jr. An Ab Initio Quantum Mechanical Study of Hydrogen-Bonded Complexes of Biological Interest. J. Phys. Chem  A, 2002, 106: 7820-7827.
  7. Yongping Pan, Niu Huang, Sam Cho and Alexander D. MacKerell, Jr. Consideration of Molecular Weight During Compound Selection in Virtual Target-Based Database Screening.  J. Chem. Inf. Comput. Sci. 2003;43(1); 267-272
  8. Niu Huang, Nilesh K. Banavali and Alexander D. MacKerell, Jr. Protein-facilitated base flipping in DNA by cytosine-5-methyltransferase. Proc. Natl. Acad. Sci. U S A, 2003, 100: 68-73.
  9. Hui Peng#, Niu Huang#, Jing Qi, Ping Xie, Chen Xu, Jianxiang Wang and Chunzheng Yang. Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg. Med. Chem. Lett. 2003, 13(21):3693-3699.  # equal contribution
  10. Niu Huang and Alexander D. MacKerell, Jr. Atomistic view of Base flipping in DNA. Phil. Trans. Roy. Soc. Lond. Series A. 2004, 362: 1-22.
  11. Niu Huang, Ashish Nagarsekar, Guanjun Xia, Jun Hayashi and Alexander D. MacKerell, Jr. Identification of Non-Phosphate-Containing Small Molecular Weight Inhibitors of the Tyrosine Kinase p56 Lck SH2 Domain via in Silico Screening against the pY+3 Binding Site. J. Med. Chem. 2004, 47 (14):3502-3511.
  12. John R. Horton, Gary Ratner, Nilesh K. Banavali, Niu Huang, Yongseok Choi, Martin A. Maier, Victor E. Marquez, Alexander D. MacKerell, Jr., Xiaodong Cheng. Caught in the Middle of the Act: Visualization of a Putative Transition State During DNA Base Flipping. Nucl. Acids. Res. 2004, 32: 3877-3886.
  13. Niu Huang and Alexander D. MacKerell, Jr. Specificity in protein-DNA interactions: Energetic recognition by the (cytosine-C5)-methyltransferase from HhaI. J. Mol. Biol. 2005, 345:265-274.
  14. Victor M. Anisimov, Guillaume Lamoureux, Igor V. Vorobyov, Niu Huang, Benoit Roux, Alexander D. MacKerell, Jr. Determination of Electrostatic Parameters for a polarizable Force Field Based on the Classical Drude Oscillator. J. Chem. Theory. Comp. 2005, 1: 153-168.
  15. Niu Huang, Chakrapani Kalyanaraman, John Irwin, Matthew P. Jacobson. Physics-based Scoring of Protein-ligand Complexes: Enrichment of known inhibitors in Large-Scale Virtual Screening. J. Chem. Inf. Model. 2006, 46:243-253.
  16. Nilesh K. Banavali, Niu Huang and Alexander D. MacKerell, Jr. Conserved Patterns in Backbone Torsion Changes Allow For Single Base Flipping from Duplex DNA with Minimal Distortion of the Double Helix. J. Phys. Chem. B. 2006, 110:10997-11004.
  17. Niu Huang, Chakrapani Kalyanaraman, Katarzyna Bernacki and Matthew P. Jacobson. Ligand Binding Free-energy Calculations via Physics-based Scoring Methods. Phys. Chem. Chem. Phys. 2006, 8:5166-5177.
  18. Niu Huang, John Irwin and Brian Shoichet. Benchmarking Sets for Molecular Docking. J. Med. Chem. 2006, 49:6789-6801.
  19. Niu Huang and Matthew P. Jacobson. Physics-based Methods for Studying Protein-Ligand Interactions. Curr. Opin. Drug Discov. Devel. 2007, 10:325-331.
  20. Linjie Chen, Huayi Wang, Jie Zhang, Lichuan Gu, Niu Huang, Jian-Min Zhou and Jijie Chai. Structural basis for the catalytic mechanism of phosphothreonine lyase. Nat. Struct. Mol. Biol. 2008, 15:101-102
  21. Niu Huang and Brian Shoichet. Exploring Ordered Waters in Molecular Docking. J. Med. Chem. 2008, 51:4862-4865
  22. Zhiwei Huang, Yingcai Feng, Xiaojing Wu, Xiaojun Wang, Xingguo Xiao, Wenhui Li, Niu Huang, Lichuan Gu, Guangming Zhong and Jijie Chai. Structural and biochemical mechanisms of the catalysis, activation and inhibition of CPAF (Chlamydial Protease/Proteasome-like Activity Factor). Cell Host & Microbe. 2008, 4: 529-542
  23. Qing Yao, Jixin Cui, Yongqun Zhu, Guolun Wang, Liyan Hu, Chengzu Long, Ran Cao, Xinqi Liu, Niu Huang, She Chen, Liping Liu and Feng Shao. A bacterial type III effector family uses the papain-like hydrolytic activity to arrest the host cell cycle. Proc. Natl. Acad. Sci. U S A. 2009, 106:3716-3721
  24. Chaya S. Rapp, Cheryl Schonbrun, Matthew P. Jacobson, Chakrapani Kalyanaraman and Niu Huang. Automated Site Preparation in Rescoring of Receptor Ligand Complexes. Proteins. 2009, 77:52-61
  25. John Irwin, Brian Shoichet, Michael Mysinger, Niu Huang, Francesco Colizzi, Pascal Wassam and Yiqun Cao. Automated docking screens: a feasibility study. J. Med. Chem. 2009, 52:5712-20
  26. Niu Huang and Matthew P. Jacobson. Binding-Site Assessment by Virtual Fragment Screening. PLoS ONE. 2010, 5: e10109
  27. Qiang Pei, Andrew Christofferson, Hui Zhang, Jijie Chai and Niu Huang. Computational Investigation of the Enzymatic Mechanisms of Phosphothreonine Lyase. Biophys. Chem. 2011, 157:16-23.
  28. Andrew Christofferson, Lifeng Zhao, Hanzi Sun, Zhen Huang and Niu Huang. Theoretical Studies of the Base Pair Fidelity of Selenium-modified DNA. J. Phys. Chem B. 2011, 115:10041-8.
  29. Lifeng Zhao, Chuanjie Wu and Niu Huang. Mutual Solubilities Study for Binary Mixtures of Dipropylene Glycol Dimethyl Ether and Water via Molecular Dynamics Simulation and AMOEBA Polarizable Force Field. Fluid. Phase. Equilib. 2011, 310: 32-8.
  30. Andrew Christofferson and Niu Huang. How to Benchmark Methods for Structure-Based Virtual Screening of Large Compound Libraries. Methods in Molecular Biology. 2012. 819:187-95.
  31. Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, Wu X, Yao X, Mao Q, Li X, Dong W, Wan X, Huang N, Shen X, Liang Z, Li W. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J. Biol. Chem. 2012, 287:6406-20.
  32. Xingyu Lin, Xiping Huang, Gang Chen, Ryan Whaley, Shiming Peng, Yanli Wang, Guoliang Zhang, Shaohui Wang, Xiang Wang, Brian Roth and Niu Huang. Life Beyond Kinases: Structure-Based Discovery of Sorafenib as Nanomolar Antagonist of 5-HT Receptors. J. Med. Chem. 2012, 55:5749-59. (Selected by F1000 Pharmacology & Drug Discovery, Congreve M: 2012. )
  33. Shiming Peng, Xingyu Lin, Zongru Guo and Niu Huang. Identifying Multiple-Target Ligands via Computational Chemogenomics Approaches.  Curr. Top. Med. Chem. 2012, 12:1363-1375.
  34. Ran Cao, Minyu Liu, Min Yin, Quanhai Liu, Yanli Wang and Niu Huang. Discovery of Novel Tubulin Inhibitors via Structure-Based Hierarchical Virtual Screening. J. Chem. Inf. Model. 2012, 52:2730-40.
  35. Qing Yao, Jixin Cui, Jiayi Wang, Ting Li, Xiaobo Wan, Tianming Luo, Yi-Nan Gong, Ying Xu, Niu Huang and Feng Shao. Structural mechanism of ubiquitin and NEDD8 deamidation catalyzed by bacterial effectors that induce macrophage-specific apoptosis. Proc. Natl. Acad. Sci. U S A. 2012,109:20395-400.
  36. Yanli Wang, Minyu Liu, Ran Cao, Ming Yin, Riuhua Xiao, Quanhai Liu and Niu Huang. A Soluble Bis-chelated Gold(I) Diphosphine Compound with Strong Anticancer Activity and Low Toxicity. J. Med. Chem., 2013, 56 (4), pp 1455–1466
  37. Yao Wu, Xiaodong Dai, Niu Huang* and Lifeng Zhao*. A partition function-based weighting scheme in force field parameter development using ab initio calculation results in global configurational space. Journal of Computational Chemistry. Volume 34, Issue 15, pages 1271–1282, 5 June 2013
  38. Xiaobo Wan, Wei Zhang, Li Li, Yuting Xie, Wei Li and Niu Huang. A New Target for An Old Drug: Identifying Mitoxantrone as a Nanomolar Inhibitor of PIM1 Kinase via Kinome-wide Selectivity Modeling. J. Med. Chem., 2013, 56 (6), pp 2619–2629
  39. Xiaobo Wan, Yue Ma, Christopher L. McClendon, Lily Jun-shen Huang and Niu Huang. Ab Initio Modeling and Experimental Assessment of Janus Kinase 2 (JAK2) Kinase-Pseudokinase Complex Structure. PLoS Comp. Biol. 2013.
  40. Fanqi Zeng, Shiming Peng, Li Li, Libing Mu, Zhenghua Zhang, Zhiyuan Zhang and Niu Huang. HAT off: structure-based identification of drug-like inhibitors of p300 histone acetyltransferase. Acta Pharmaceutica Sinica. 2013, 48:700-708.
  41. Shiming Peng, Yu Zhou and Niu Huang. Improving the accuracy of pose prediction in molecular docking via structural filtering and conformational clustering. Chinese Chem. Lett. 2013, 24:1001-1004.
  42. Ran Cao, Wei Li, Hanzi Sun, Yu Zhou and Niu Huang. Computational chemistry in structure-based drug design. Acta Pharmaceutica Sinica. 2013, 48:1041-1052.
  43. Hanzi Sun, Lifeng Zhao, Shiming Peng and Niu Huang. Incorporating Replacement Free Energy of Binding-site Waters in Molecular Docking. Proteins. 2014, 82:1765-76.
  44. Wei Li, Xiaobo Wan, Wei Zhang, Fanqi Zeng, Yanli Wang, Yuting Xie, Li Li and Niu Huang. More than just GPCR Ligand: Structure-based Discovery of Thioridazine Derivatives as Pim-1 Kinase Inhibitors. Med. Chem.Commun. 2014, 5:507-511.
  45. Yu Zhou, Chao Wu, Lifeng Zhao and Niu Huang. Exploring the early stages of the pH-induced conformational change of influenza hemagglutinin. Proteins. 2014, 82:2412-28.
  46. Deng M, Lu Z, Zheng J, Wan X, Chen X, Hirayasu K, Sun H, Lam Y, Chen L, Wang Q, Song C, Huang N, Gao GF, Jiang Y, Arase H, Zhang CC. A motif in LILRB2 critical for Angptl2 binding and activation. Blood. 2014, 124:924-35.
  47. Ran Cao, Niu Huang and Yanli Wang. Evaluation and application of MD-PB/SA in structure-based hierarchical virtual screening. J Chem Inf Model. 2014, 54:1987-96.
  48. Yao Q, Lu Q, Wan X, Song F, Xu Y, Hu M, Zamyatina A, Liu X, Huang N, Zhu P, Shao F. A structural mechanism for bacterial autotransporter glycosylation by a dodecameric heptosyltransferase family. Elife. 2014, Oct 13;3. doi: 10.7554/eLife.03714.
  49. Yao Q, Zhang L, Wan X, Chen J, Hu L, Ding X, Li L, Karar J, Peng H, Chen S, Huang N, Rauscher FJ, Shao F. (2014) Structure and Specificity of the Bacterial Cysteine Methyltransferase Effector NleE Suggests a Novel Substrate in Human DNA Repair Pathway. PLoS Pathog. 2014, 10(11): e1004522.
  50. Yu zhou and Niu Huang. Binding site druggability assessment in fragment-based drug design.. Methods Mol. Biol. 2015, 1289:13-21.
  51. Dong T, Li C, Wang X, Dian L, Zhang X, Li L, Chen S, Cao R, Li L, Huang N, He S, Lei X. Ainsliadimer A selectively inhibits IKKα/β by covalently binding a conserved cysteine. Nat Commun. 2015, 6:6522.
  52. Hu Z, Wan X, Hao R, Zhang H, Li L, Li L, Xie Q, Wang P, Gao Y, Chen S, Wei M, Luan Z, Zhang A, Huang N, Chen L. Phosphorylation of mutationally introduced tyrosine in the activation loop of HER2 confers gain-of-function activity. PLoS One. 2015,10(4):e0123623.
  53. Ran Cao, Yanli Wang and Niu Huang. Discovery of 2-Acylaminothiophene-3-Carboxamides as Multitarget Inhibitors for BCR-ABL Kinase and Microtubules. J Chem Inf Model. 2015, 55(11):2435-42.
  54. Yu Zhou, Jing Ma, Xinyu Lin, Xiping Huang, Kaichun Wu and Niu Huang. Structure-Based Discovery of Novel and Selective 5-Hydroxytryptamine 2B Receptor Antagonists for the Treatment of Irritable Bowel Syndrome. J. Med. Chem. 2016, 59(2):707-20.
  55. Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, Sun HY, Li A, Ping XL, Lai WY, Wang X, Ma HL, Huang CM, Yang Y, Huang N, Jiang GB, Wang HL, Zhou Q, Wang XJ, Zhao YL, Yang YG. Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing. Mol Cell. 2016, 61(4):507-19.
  56. Liu JJ, Niu CY, Wu Y, Tan D, Wang Y, Ye MD, Liu Y, Zhao W, Zhou K, Liu QS, Dai J, Yang X, Dong MQ, Huang N, Wang HW. CryoEM structure of yeast cytoplasmic exosome complex. Cell Res. 2016, 26(7):822-37.
  57. Liu X, Dong T, Zhou Y, Huang N, Lei X. Exploring the Binding Proteins of Glycolipids with Bifunctional Chemical Probes. Angew Chem Int Ed Engl. 2016, 55(46):14330-14334.
  58. Zhu Q, Venzke D, Walimbe AS, Anderson ME, Fu Q, Kinch LN, Wang W, Chen X, Grishin NV, Huang N, Yu L, Dixon JE, Campbell KP, Xiao J. Structure of protein O-mannose kinase reveals a unique active site architecture. Elife. 2016, 5. pii: e22238.
  59. Zhang L, Sun H, Chen Z, Liu Z, Huang N, Qian F.Intermolecular interactions between co-encapsulated drugs inhibit drug crystallization and enhance colloidal stability of polymeric micelles. Mol Pharm. 2017 Aug 22. doi:10.1021/acs.molpharmaceut.7b00591. [Epub ahead of print] PMID:28829143